Rigel Pharmaceuticals (RIGL) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.71% |
| Dec 31, 2025 | -18.47% |
| Sep 30, 2025 | -53.49% |
| Jun 30, 2025 | 378.38% |
| Mar 31, 2025 | -23.31% |
| Dec 31, 2024 | 18.49% |
| Sep 30, 2024 | 3,044.52% |
| Jun 30, 2024 | 106.42% |
| Mar 31, 2024 | -454.32% |
| Dec 31, 2023 | 144.03% |
| Sep 30, 2023 | 15.23% |
| Jun 30, 2023 | 58.61% |
| Mar 31, 2023 | -712.07% |
| Dec 31, 2022 | 111.30% |
| Sep 30, 2022 | -41.94% |
| Jun 30, 2022 | 50.63% |
| Mar 31, 2022 | -22.61% |
| Dec 31, 2021 | -8.25% |
| Sep 30, 2021 | -51.63% |
| Jun 30, 2021 | -131.25% |
| Mar 31, 2021 | 321.78% |
| Dec 31, 2020 | -36.62% |
| Sep 30, 2020 | 20.76% |
| Jun 30, 2020 | -182.71% |
| Mar 31, 2020 | 221.28% |
| Dec 31, 2019 | -44.03% |
| Sep 30, 2019 | 43.59% |
| Jun 30, 2019 | -16.11% |
| Mar 31, 2019 | -825.83% |
| Dec 31, 2018 | 110.39% |
| Sep 30, 2018 | 6.67% |
| Jun 30, 2018 | -5.57% |
| Mar 31, 2018 | 5.65% |
| Dec 31, 2017 | -46.82% |
| Sep 30, 2017 | 7.70% |
| Jun 30, 2017 | -19.39% |
| Mar 31, 2017 | -2.63% |
| Dec 31, 2016 | 30.57% |
| Sep 30, 2016 | -66.61% |
| Jun 30, 2016 | 22.31% |
| Mar 31, 2016 | -37.81% |
| Dec 31, 2015 | -87.98% |
| Sep 30, 2015 | 51.47% |
| Jun 30, 2015 | 23.39% |
| Mar 31, 2015 | 18.45% |
| Dec 31, 2014 | -6.31% |
| Sep 30, 2014 | 17.35% |
| Jun 30, 2014 | -13.72% |
| Mar 31, 2014 | -32.11% |
| Dec 31, 2013 | 29.19% |
| Sep 30, 2013 | -4.57% |
| Jun 30, 2013 | 10.99% |
| Mar 31, 2013 | -0.37% |
| Dec 31, 2012 | -0.18% |
| Sep 30, 2012 | -2.76% |
| Jun 30, 2012 | -6.74% |
| Mar 31, 2012 | 10.03% |
| Dec 31, 2011 | -43.62% |
| Sep 30, 2011 | 16.31% |
| Jun 30, 2011 | -3.34% |
| Mar 31, 2011 | -6.06% |
| Dec 31, 2010 | -139.06% |
| Sep 30, 2010 | 86.66% |